. 2019 Sep 30;60(3):E184–E190. doi: 10.15167/2421-4248/jpmh2019.60.3.1315
©2019 Pacini Editore SRL, Pisa, Italy
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Fig. 1.
Seroprevalence against HBV according to the age at primary vaccination course.